Viridian Therapeutics, Inc.\DE

Ownership Transactions Reported by 18 Insiders

Symbol
VRDN on Nasdaq
Industry
Services-Medical Laboratories
Location
221 Crescent Street, Suite 103 A, Waltham, MA

Insiders trading volume in the past year

Viridian Therapeutics, Inc.\DE executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director, 10%+ Owner $64.6M +$40M +163% Sep 13, 2024
Frazier Life Sciences Public Fund, L.P. 10%+ Owner $31.6M Sep 23, 2021
Jonathan Violin Chief Executive Officer, Director $10.1M Feb 2, 2023
Scott Myers Chief Executive Officer, Director $5.45M Apr 12, 2023
Lara Meisner Chief Legal Officer $629K Jun 15, 2023
Stephen Mahoney President and CEO, Director $499K +$499K Sep 27, 2024
Thomas Beetham Chief Operating Officer $140K +$117K +500% Sep 27, 2024
Thomas Ciulla Chief Medical Officer $16K Feb 5, 2024
Carrie Melvin Coo Feb 8, 2023
Jennifer Tousignant Chief Legal Officer Feb 12, 2024
Seth Harmon Senior Vice President of Finance Nov 10, 2023
Sarah Gheuens Director Jun 26, 2024
Peter Evan Harwin Director Jun 26, 2024
Tomas Kiselak Director Jun 26, 2024
Kristian Humer CFO and CBO Feb 8, 2023
Arlene Morris Director Jun 26, 2024
Jennifer K. Moses Director Jun 26, 2024
Barrett Katz Chief Medical Officer Feb 8, 2023

Recent Insider Transactions by Companies or Individuals for Viridian Therapeutics, Inc.\DE

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.